HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M600488-JLR200v1 48/4/869    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Beltroy, E. P. Articles by Turley, S. D. Search for Related Content PubMed PubMed Citation Articles by Beltroy, E. P. Articles by Turley, S. D. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 48, 869-881, April 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology

Lysosomal unesterified cholesterol content correlates with liver cell death in murine Niemann-Pick type C disease

Eduardo P. Beltroy, Benny Liu, John M. Dietschy and Stephen D. Turley¹

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-8887

Published, JLR Papers in Press, January 14, 2007.

¹ To whom correspondence should be addressed. e-mail: stephen.turley{at}utsouthwestern.edu

Niemann-Pick type C (NPC) disease is a multisystem disorder resulting from mutations in the NPC1 gene that encodes a protein involved in intracellular cholesterol trafficking. Significant liver dysfunction is frequently seen in patients with this disease. The current studies used npc1 mutant mice to investigate the association between liver dysfunction and unesterified cholesterol accumulation, a hallmark of NPC disease. Data from 92 npc1^–/– mice (age range, 9–56 days) revealed a significant positive correlation between the plasma activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) and whole liver cholesterol content. In 56 day old npc1^–/– mice that had been fed from 35 days of age a rodent diet or the same diet containing either cholesterol (1.0%, w/w) or ezetimibe (a sterol absorption inhibitor; 0.0125%, w/w), whole liver cholesterol content averaged 33.5 ± 1.1, 87.9 ± 1.7, and 20.8 ± 0.9 mg, respectively. Again, plasma ALT and AST activities were positively correlated with hepatic cholesterol content. In contrast, plasma transaminase levels remained in the normal range in npc1^+/+ mice, in which hepatic esterified cholesterol content had been increased by 72-fold by feeding a high-cholesterol, high-fat diet. These studies suggest that the late endosomal/lysosomal content of unesterified cholesterol correlates with cell damage in NPC disease.

Supplementary key words hepatic dysfunction • chylomicron cholesterol • low density lipoprotein receptor • biliary bile acid • hepatomegaly • small intestine

Abbreviations: ALT, alanine aminotransferase; apoE, apolipoprotein E; AST, aspartate aminotransferase; bw, body weight; CMr, chylomicron remnant; LDLR, low density lipoprotein receptor; NPC, Niemann-Pick type C; NPC1L1, Niemann-Pick C1-Like 1; VLDLr, very low density lipoprotein remnant

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Liu, S. D. Turley, D. K. Burns, A. M. Miller, J. J. Repa, and J. M. Dietschy From the Cover: Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse PNAS, February 17, 2009; 106(7): 2377 - 2382. [Abstract] [Full Text] [PDF]

				S. L. Sturley, M. C. Patterson, and P. Pentchev Unraveling the sterol-trafficking defect in Niemann-Pick C disease PNAS, February 17, 2009; 106(7): 2093 - 2094. [Full Text] [PDF]

				V. M. Rimkunas, M. J. Graham, R. M. Crooke, and L. Liscum TNF-{alpha} plays a role in hepatocyte apoptosis in Niemann-Pick type C liver disease J. Lipid Res., February 1, 2009; 50(2): 327 - 333. [Abstract] [Full Text] [PDF]

				T. Kaptzan, S. A. West, E. L. Holicky, C. L. Wheatley, D. L. Marks, T. Wang, K. B. Peake, J. Vance, S. U. Walkley, and R. E. Pagano Development of a Rab9 Transgenic Mouse and Its Ability to Increase the Lifespan of a Murine Model of Niemann-Pick Type C Disease Am. J. Pathol., January 1, 2009; 174(1): 14 - 20. [Abstract] [Full Text] [PDF]

				M. A. Valasek, J. J. Repa, G. Quan, J. M. Dietschy, and S. D. Turley Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G813 - G822. [Abstract] [Full Text] [PDF]

				H. Li, S. D. Turley, B. Liu, J. J. Repa, and J. M. Dietschy GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice J. Lipid Res., August 1, 2008; 49(8): 1816 - 1828. [Abstract] [Full Text] [PDF]

				B. Liu, H. Li, J. J. Repa, S. D. Turley, and J. M. Dietschy Genetic variations and treatments that affect the lifespan of the NPC1 mouse J. Lipid Res., March 1, 2008; 49(3): 663 - 669. [Abstract] [Full Text] [PDF]

				J. J. Repa, H. Li, T. C. Frank-Cannon, M. A. Valasek, S. D. Turley, M. G. Tansey, and J. M. Dietschy Liver X Receptor Activation Enhances Cholesterol Loss from the Brain, Decreases Neuroinflammation, and Increases Survival of the NPC1 Mouse J. Neurosci., December 26, 2007; 27(52): 14470 - 14480. [Abstract] [Full Text] [PDF]

				B. Liu, C. Xie, J. A. Richardson, S. D. Turley, and J. M. Dietschy Receptor-mediated and bulk-phase endocytosis cause macrophage and cholesterol accumulation in Niemann-Pick C disease J. Lipid Res., August 1, 2007; 48(8): 1710 - 1723. [Abstract] [Full Text] [PDF]